Bridge recombinases are a class of naturally occurring RNA-guided DNA recombinases. We previously demonstrated they can programmably insert, excise, and invert DNA in vitro and in bacteria. Here, we r...

An interview with Patrick Hsu, 31, Harvard PhD grad and CRISPR pioneer, who co-founded Arc Institute and helped develop Evo 2, a biology-focused AI model.

Arc Institute today launched the Arc Virtual Cell Atlas, a growing resource for computation-ready single-cell measurements, starting with data from over 300 million cells. The initial release of the A...

Building predictive models of the cell requires systematically mapping how perturbations reshape each cell's state, function, and behavior. Here, we present Tahoe-100M, a giga-scale single-cell atlas ...

YouTube video by No Priors: AI, Machine Learning, Tech, & Startups

Evo 2 now includes information from humans, plants, and other eukaryotic species to expand its capabilities in generative functional genomics.

Arc Institute develops the largest AI model for biology to date in collaboration with NVIDIA, bringing together Stanford University, UC Berkeley, and UC San Francisco researchers

BioNeMo Framework: For building and adapting AI models in drug discovery at scale - NVIDIA/bionemo-framework

Arc Institute is a independent nonprofit research organization headquartered in Palo Alto, California.